← Back to headlines




Jim Cramer Labels Beam Therapeutics a "Speculative Situation"
Financial analyst Jim Cramer characterized Beam Therapeutics as a "speculative situation," indicating a high-risk, high-reward investment.
30 Apr, 19:17 — 30 Apr, 19:17
Sources
Showing 1 of 1 sources
Related Stories

Elon Musk Condemns New Documentary as 'Hit Piece' and Threatens Legal Action
44m ago

UAE Announces $46 Billion Investment Plan to Strengthen Economic Ties with Germany
46m ago

TTM Technologies Prices $500 Million Senior Notes
1h ago
Adobe Beats Q3 Revenue Estimates Despite Wall Street Demand for More AI Growth
1h ago